Direct renin inhibitors for preventing the progression of diabetic kidney disease

  • Protocol
  • Intervention

Authors

  • Vidhu Anand,

    1. University of Minnesota, Department of Surgery, Minneapolis, MN, USA
    Search for more papers by this author
  • Abhijit V Kshirsagar,

    Corresponding author
    1. University of North Carolina at Chapel Hill, Department of Medicine, Chapel Hill, NC, USA
    • Abhijit V Kshirsagar, Department of Medicine, University of North Carolina at Chapel Hill, 348 Macnider, Chapel Hill, NC, 27599-7155, USA. abhijit_kshirsagar@med.unc.edu.

    Search for more papers by this author
  • Sankar D Navaneethan,

    1. Glickman Urological and Kidney institute, Cleveland Clinic, Department of Nephrology and Hypertension, Cleveland, OH, USA
    Search for more papers by this author
  • Giovanni FM Strippoli,

    1. The Children's Hospital at Westmead, Cochrane Renal Group, Centre for Kidney Research, Westmead, NSW, Australia
    2. University of Bari, Department of Emergency and Organ Transplantation, Bari, Italy
    3. Mario Negri Sud Consortium, Department of Clinical Pharmacology and Epidemiology, Santa Maria Imbaro, Italy
    4. The University of Sydney, Sydney School of Public Health, Sydney, Australia
    5. Diaverum, Medical-Scientific Office, Lund, Sweden
    Search for more papers by this author
  • Nagendra Boopathy Senguttuvan,

    1. All India Institute of Medical Sciences, Department of Cardiology, New Delhi, Delhi, India
    Search for more papers by this author
  • Sushil K Garg,

    1. University of Minnesota, Department of Surgery, Minneapolis, MN, USA
    Search for more papers by this author
  • Heejung Bang

    1. University of California, Division of Biostatistics, Davis, CA, USA
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

This review aims to look at the benefits and harms of direct renin inhibitors in preventing progression or onset of DKD.